FEASIBILITY STUDIES, CLINICAL TRIAL READINESS, GMP/CLINICAL TRIAL MATERIALS

NIH RePORTER · NIH · N01 · $89,686 · view on reporter.nih.gov ↗

Abstract

This study is part of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed scientific solutions to understand the basis of pain and enhance clinical pain management.” Drug Manufacturing and Formulation Program; FEASIBILITY STUDIES; CLINICAL TRIAL READINESS; Good Manufacturing Practice; CLINICAL TRIAL MATERIALS

Key facts

NIH application ID: 11091392
Project number: 271201500005I-P00001-759502200001-1
Recipient: ALBANY MOLECULAR RESEARCH, INC.
Principal Investigator: MELISSA ALLARD
Activity code: N01
Funding institute: NIH
Fiscal year: 2024
Award amount: $89,686
Award type: —
Project period: 2022-07-07 → 2027-07-06